Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 06, 2016 |
referred to health |
Jan 07, 2015 |
referred to health |
Senate Bill S660
2015-2016 Legislative Session
Sponsored By
(D, WF) Senate District
Archive: Last Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
(D) Senate District
(D, WF) Senate District
(D, WF) 28th Senate District
2015-S660 (ACTIVE) - Details
- Current Committee:
- Senate Health
- Law Section:
- Public Health Law
- Laws Affected:
- Add §3317, Pub Health L; add §19.18-b, Ment Hyg L
- Versions Introduced in Other Legislative Sessions:
-
2011-2012:
S6179
2013-2014: S547
2017-2018: S687
2019-2020: S1530
2015-S660 (ACTIVE) - Summary
Requires disclosure of addiction risks for certain prescription drugs; requires physicians, nurses and pharmacists to provide information on prevention, mitigation and treatment of prescription drug addiction and to have the patient sign a form acknowledging education of such risks.
2015-S660 (ACTIVE) - Sponsor Memo
BILL NUMBER: S660 TITLE OF BILL : An act to amend the public health law and the mental hygiene law, in relation to requiring disclosure of addiction risks for certain prescription drugs PURPOSE : This bill requires disclosure of addiction risks for certain prescription drugs. SUMMARY OF PROVISIONS : Section 1 defines the bill as Michael David Israel patient information act. Section 2 defines opiate analgesics and psychotropic drugs and amends public health law to require that prescribers and pharmacists make patients aware of the risk of addiction and local resources to treat addiction to prescription drugs prior to prescribing or dispensing such drugs. Section 2 also requires that patients sign a waiver stating that they understand the risks of addiction and that they have been provided with information about local resources in the event that they become addicted. In addition section 2 provides a fine scale for failure to
2015-S660 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 660 2015-2016 Regular Sessions I N S E N A T E (PREFILED) January 7, 2015 ___________ Introduced by Sens. KENNEDY, AVELLA, HASSELL-THOMPSON, KRUEGER -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law and the mental hygiene law, in relation to requiring disclosure of addiction risks for certain prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. This act shall be known and may be cited as the "Michael David Israel patient information act". S 2. The public health law is amended by adding a new section 3317 to read as follows: S 3317. REQUIRED DISCLOSURES. 1. DEFINITIONS. FOR PURPOSES OF THIS SECTION: (A) "OPIATE ANALGESICS" SHALL MEAN THE MEDICINES BUPRENORPHINE, BUTOR- PHANOL, CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE, MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE AND PROPOXYPHENE AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS. (B) "PSYCHOTROPIC DRUGS" SHALL MEAN ANY DRUG OR MEDICINE THAT AFFECTS MENTAL ACTIVITY, BEHAVIOR OR PERCEPTION INCLUDING ANTI-PSYCHOTICS, ANTI- DEPRESSANTS, ANTI-ANXIETY DRUGS OR ANXIOLYTICS AND HYPNOTICS. 2. DISCLOSURES. WHENEVER A PRACTITIONER, PHARMACIST, REGISTERED NURSE OR ANY OTHER PERSON WHO IS AUTHORIZED TO DISTRIBUTE SUBSTANCES REGULATED BY THIS ARTICLE, DISPENSES OPIATE ANALGESICS OR PSYCHOTROPIC DRUGS SUCH PRESCRIBING PHYSICIAN, NURSE OR PHARMACIST SHALL: (A) DESCRIBE THE RISKS OF ADDICTION TO THE PATIENT; (B) AFTER CONSULTING THE PATIENT'S MEDICAL HISTORY, INFORM THE PATIENT OF HIS OR HER CHANCE OF ADDICTION; EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03249-01-5
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.